Try our Advanced Search for more refined results

USA v. Holmes et al

  1. February 09, 2021

    Ex-Theranos COO's Fraud Trial Moved To January 2022

    A California federal judge on Tuesday pushed back former Theranos chief operating officer Ramesh "Sunny" Balwani's criminal fraud trial over the blood-testing startup to January 2022, after delaying former Theranos CEO Elizabeth Holmes' trial in a companion case from March to July due to the coronavirus pandemic.

  2. January 28, 2021

    Paul Weiss-Bound Orrick Attys Exit Theranos Case

    Former U.S. Attorney Melinda Haag and two other Orrick Herrington & Sutcliffe partners who recently left for Paul Weiss received permission Wednesday to exit the fraud defense team of former Theranos Chief Operating Officer Sunny Balwani.

  3. January 12, 2021

    Feds Want Jury Told Of Ex-Theranos CEO's 'Lavish Lifestyle'

    Prosecutors have asked a California federal judge to deny former Theranos CEO Elizabeth Holmes' request to exclude testimony regarding her wealth and "lavish lifestyle" from an upcoming criminal fraud trial, arguing that the information shows she had a "powerful motive" to defraud investors, doctors and the public.

  4. January 03, 2021

    2021 Trials To Watch As Litigants Return To Court — Hopefully

    After a year in which the coronavirus pandemic swiped numerous important trials off the table, 2021 is widely hoped to bring broad vaccine availability and a return to the courtroom for many who have been awaiting their days in court.

  5. December 21, 2020

    Ex-Theranos CEO's Fraud Trial Moved To July Due To Virus

    A California federal judge on Friday rescheduled former Theranos CEO Elizabeth Holmes' criminal jury trial from March to July, delaying the closely watched fraud trial against the beleaguered blood-testing startup founder for the third time since it was originally set due to the coronavirus pandemic.

  6. December 16, 2020

    Ex-Theranos CEO, Feds Spar Over Atty-Client Privilege

    Ex-Theranos CEO Elizabeth Holmes and prosecutors fought before a California magistrate judge Wednesday over the standard for deciding whether Holmes had an individual attorney-client relationship with Theranos' counsel at Boies Schiller Flexner LLP.

  7. December 07, 2020

    Ex-Theranos CEO Claims Doc Privilege Via Boies Schiller

    The former CEO and founder of Theranos says she doesn't have to give up witness interviews and other documents relating to allegations that she and her partner sold blood-testing technology they knew didn't work, arguing Friday that the materials fall under her attorney-client relationship with Boies Schiller Flexner LLP.

  8. December 02, 2020

    Theranos Judge Says Virus Won't Delay Ex-CEO's March Trial

    A California federal judge told counsel Wednesday he doesn't plan to further delay the in-person criminal jury trial of ex-Theranos CEO Elizabeth Holmes due to the coronavirus pandemic, saying he's "hopeful and optimistic" that the monthslong trial will start March 9 with new courtroom safety protocols in place.

  9. November 23, 2020

    Feds Say No Privilege For Ex-Theranos CEO In Fraud Case

    The U.S. government is asking a California federal judge to make the former CEO and founder of Theranos turn over witness interviews and other documents relating to allegations that she and her partner sold blood-testing technology they knew didn't work, saying she can't assert attorney-client privilege for work done for the now-defunct company.

  10. October 13, 2020

    Theranos Founder Elizabeth Holmes Can't Shake New Charges

    A California federal judge on Tuesday rejected attempts by ex-Theranos CEO Elizabeth Holmes to dismiss fresh charges accusing her of defrauding Walgreens, Safeway and others, finding they are not time barred or "so substantially" broad that she wasn't on notice of them.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!